Notice Type
Departmental
Notice Title

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Agenerase
Active Ingredient: Amprenavir 150mg
Dosage Form: Capsule
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: R P Scherer SA, Beinheim, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Agenerase
Active Ingredient: Amprenavir 50mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: R P Scherer SA, Beinheim, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Agenerase
Active Ingredient: Amprenavir 15mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer: Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 10th day of May 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).